Seeing Is Believing
Currently out of the existing stock ratings of Keith Markey, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Keith Markey, carries an average stock price target met ratio of 30% that have a potential upside of 37.42% achieved within 98 days. Previously, Keith Markey worked at GUGGENHEIM, EVERCORE, GRIFFIN SECURITIES.
Keith Markey’s has documented 26 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PGEN, Precigen at 06-Jun-2016.
Analyst best performing recommendations are on XON (PRECIGEN).
The best stock recommendation documented was for XON (PRECIGEN) at 2/23/2015. The price target of $65 was fulfilled within 163 days with a profit of $25.7 (65.39%) receiving and performance score of 4.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Oct-2017
$27
$24.28 (892.65%)
6 years 10 months 17 days ago
(13-Nov-2019)
0/3 (0%)
$21.53 (393.60%)
Buy Since 19-Oct-2015
$50
7 years 6 months 29 days ago
(01-Mar-2019)
1/3 (33.33%)
$16.58 (49.61%)
37
Buy Since 10-Nov-2015
$57
$54.28 (1995.59%)
$69
10 years 6 months 29 days ago
(01-Mar-2016)
0/3 (0%)
$23.59 (70.61%)
Hold Since 10-Nov-2015
$28
10 years 7 months ago
(01-Mar-2016)
1/2 (50%)
$1.52 (5.74%)
3
Buy Since 23-Feb-2015
$65
$62.28 (2289.71%)
$65
10 years 8 months 2 days ago
(28-Jan-2016)
2/4 (50%)
$36.28 (126.32%)
146